Search Keyword:


Search option:


IID00207
UniprotQ04206
ProteinTranscription factor p65
GeneRELA
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
551
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 20-291 Hetero tetramer : IID00710Complex
 Evidence X-RAY 3gut G Reference
       Region 3gut G 20-291 order
 Evidence X-RAY 3gut E Reference
       Region 3gut E 20-291 order
 Evidence X-RAY 3gut C Reference
       Region 3gut C 20-291 order
 Evidence X-RAY 3gut A Reference
       Region 3gut A 20-291 order
Seq 20-291 Hetero dimer : IID00079Complex,IID00491Complex,IID00710Complex
 Evidence X-RAY 2o61 A Reference
       Region 2o61 A 20-291 order
Seq 20-320 Hetero trimer : IID00654Complex,IID00710Complex
 Evidence X-RAY 1nfi C Reference
       Region 1nfi C 20-320 order
 Evidence X-RAY 1nfi A Reference
       Region 1nfi A 20-314 order
       Region 1nfi A 315-320 disorder
Seq 302-316 Hetero dimer : Q8TBK2
 Evidence X-RAY 3rc0 P Reference
       Region 3rc0 P 302-306 disorder
       Region 3rc0 P 307-312 order
       Region 3rc0 P 313-316 disorder
Seq 302-316 Hetero dimer : Q8TBK2
 Evidence X-RAY 3rc0 Q Reference
       Region 3rc0 Q 302-302 disorder
       Region 3rc0 Q 303-303 order
       Region 3rc0 Q 304-316 disorder
 Evidence X-RAY 3qxy Q Reference
       Region 3qxy Q 302-302 disorder
       Region 3qxy Q 303-303 order
       Region 3qxy Q 304-316 disorder
 Evidence X-RAY 3qxy P Reference
       Region 3qxy P 302-302 disorder
       Region 3qxy P 303-303 order
       Region 3qxy P 304-316 disorder
Seq 304-316 Hetero dimer : IID00111Complex
 Evidence NMR 2lsp A Reference
       Region 2lsp A 304-316 order
Seq 308-314 Hetero dimer : IID00111Complex
 Evidence X-RAY 4kv4 B Reference
       Region 4kv4 B 308-312 order
       Region 4kv4 B 313-314 disorder
Seq 308-314 Hetero dimer : IID00111Complex
 Evidence X-RAY 4kv1 D Reference
       Region 4kv1 D 308-314 order
 Evidence X-RAY 4kv1 C Reference
       Region 4kv1 C 308-314 order
Seq 428-551
 Evidence NMR Reference
       Region 428-551 order
Seq 521-551 Hetero dimer : IID50008Complex
 Evidence NMR 5u4k B Reference
       Region 5u4k B 521-551 order
       Region 5u4k B 521-530 high_rmsd
Seq 521-551 Hetero dimer : IID50021Complex
 Evidence NMR 5urn B Reference
       Region 5urn B 521-551 order
       Region 5urn B 521-531 high_rmsd
       Region 5urn B 550-551 high_rmsd
SeqProS verified 292-320 Hetero trimer : IID00654Complex,IID00710Complex
       Region 1nfi C 20-320 order
SeqProS verified 521-551 Hetero dimer : IID50021Complex
       Region 5urn B 521-551 order
       Region 428-551 order
SeqProS verified 521-551 Hetero dimer : IID50008Complex
       Region 5u4k B 521-551 order
       Region 428-551 order
Seqphosphorylation
    75-75 (Microbial infection) Phosphoserine
    254-254 Phosphothreonine
    276-276 Phosphoserine; by RPS6KA4 and RPS6KA5
    281-281 Phosphoserine
    311-311 Phosphoserine; by PKC/PRKCZ
    435-435 Phosphothreonine
    468-468 Phosphoserine; by IKKB and IKKE
    505-505 Phosphothreonine; by CHEK1
    529-529 Phosphoserine; by CK2
    536-536 Phosphoserine; by IKKB
Seqacetylation
    1-1 N-acetylmethionine
    122-122 N6-acetyllysine; by PCAF and EP300; alternate
    123-123 N6-acetyllysine; by PCAF and EP300; alternate
    218-218 N6-acetyllysine
    221-221 N6-acetyllysine
    310-310 N6-acetyllysine; alternate
 
Prediction
NeProc
Disorder 1-15,304-551
Order 16-303
ProS 1-8,304-315,329-333,344-350,401-406,438-452,464-478,493-505,532-551
AlphaFold
Disorder 1-16,316-471,473-496,500-502,504-551
Order 17-315,472-472,497-499,503-503
Pfam Hmmer
PF00554 21-186 3e-108
PF01833 194-289 9.3e-22
SEG 374-431 ,506-528
Function
Function in SwissProt
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric RELA-NFKB1 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. The NF-kappa-B heterodimeric RELA-NFKB1 and RELA-REL complexes, for instance, function as transcriptional activators. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The inhibitory effect of I-kappa-B on NF-kappa-B through retention in the cytoplasm is exerted primarily through the interaction with RELA. RELA shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Beside its activity as a direct transcriptional activator, it is also able to modulate promoters accessibility to transcription factors and thereby indirectly regulate gene expression. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells (PubMed:15790681). The NF-kappa-B homodimeric RELA-RELA complex appears to be involved in invasin-mediated activation of IL-8 expression. Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed:33440148).